| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |